Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: A retrospective multicenter study
Top Cited Papers
- 1 April 2002
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 122 (4) , 923-930
- https://doi.org/10.1053/gast.2002.32364
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Reversibility of hepatorenal syndrome (HRS) by the administration of terlipressin and albumin. A phase-II studyJournal of Hepatology, 2000
- Multicenter Randomized Controlled Trial of Terlipressin Versus Sclerotherapy in the Treatment of Acute Variceal Bleeding: The TEST StudyHepatology, 2000
- Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndromeJournal of Hepatology, 1998
- Effect of terlipressine (Glypressine®) on hepatorenal syndrome (HRS) in cirrhotic patietns: Results of a pilot studyGastroenterology, 1998
- The Hepatorenal SyndromeClinical Science, 1997
- Hepatorenal SyndromeSeminars in Liver Disease, 1997
- Double-blind randomized controlled trial comparing terlipressin and somatostatin for acute variceal hemorrhage. Variceal Bleeding Study GroupGastroenterology, 1996
- Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis†Hepatology, 1996
- Pathogenesis and Management of the Hepatorenal SyndromeSeminars in Liver Disease, 1994
- Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascitesGastroenterology, 1993